This information is provided to you since you are being considered for the medication: Enoxaparin. The trade name of this medication is Inhixa. The aim of this page is to summarise why Enoxaparin is being considered, how it may be given and the potential side effects of the medication.
What is Enoxaparin?
Enoxaparin is part of a group of anti-coagulant medicines known as low molecular weight heparins. It reduces the risk of developing blood clots.
How Enoxaparin is given?
Enoxaparin is injected under the skin, given as a sub-cutaneous injection.
How Enoxaparin works?
It helps reduce blood clots (known as deep vein thrombi (DVT)) from forming in your leg veins.
If blood clots have formed, it helps prevent them from getting bigger or breaking off and moving to the lungs (pulmonary emboli).
The body breaks down this medication in the liver and it is excreted by the kidneys.
Why is Enoxaparin considered for all patients admitted to hospital?
There are various reasons why the prescription of Enoxaparin may be considered:
- You are admitted for a short-term illness and you may be less mobile than normal. This will increase your risk of developing blood clots in your legs.
- You may have a condition/s which may put you at increased risk of developing a blood clot, for example mechanical valve, irregular heart rhythm, COVID-19 infection or cancer.
- You may have developed a blood clot.
On admission your doctor will assess you and advised you about commencement of Enoxaparin.
Side effects of Enoxaparin
Enoxaparin may have some side effects. The most common side effects are swelling, bruising and/or an occasional droplet of blood at the injection site after you have taken out the needle.
Rarely, it may cause more significant bleeding. In the event you notice blood in your phlegm, urine and/or faeces then you must inform the staff who will stop the medication immediately.
Is Enoxaparin an animal-based product?
Enoxaparin has porcine content (derived from pigs).
My belief/diet does not allow me to take medicines that comes from animals
We understand that you may have concern regarding the porcine origin of this medication. You should raise your concerns with your health care provider if this affects you.
Are there any alternatives?
A synthetic form of anti-coagulant, that is not derived from animals, is available to prevent and treat blood clots. It is called Fondaparinux.
Your physician will advise you if you are eligible for Fondaparinux and will involve you in this discussion.
How to contact us
Respiratory department
Brunel building
Southmead Hospital
Westbury-on-Trym
Bristol
BS10 5NB